PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers

Summary

This phase I study designed in 3 parts is a randomized, placebo-controlled, sequential ascending-dose study of healthy volunteers. The safety, tolerability and pharmacokinetics of ascending single and multiple dose of Hemay007 will be assessed in Part 1 and Part 3, respectively. Food effect following a single oral dose will be evaluated in Part 2.

Timeline

Start

2017-01-09

Primary completion

2018-03

Completion

2018-03

Drugs

Indications